Skip to main content

Hidradenitis Suppurativa

Hidradenitis Suppurativa

Featured

Derm Q&A
Findings from a recent study showed patients with HS have a similar incidence to other well-studied, at-risk patient groups of opioid use, including those with newly diagnosed musculoskeletal pain. Lead study author Sarah Reddy discusses the implications of these findings and the role dermatologists play in identifying patients at-risk for opioid misuse.
News
Researchers investigated whether a yeast-exclusion diet with surgery was associated with improvements in hidradenitis suppurativa symptoms over 6 years.
Quizzes
Test your knowledge of the North American Clinical Guidelines for Hidradenitis Suppurativa.
Conferences
Dr Patel-Cohen shared clinical pearls and discussed the latest advances in the treatment of hidradenitis suppurativa. She presented on this topic at the virtual Interdisciplinary Autoimmune Summit 202
News
Findings from a recent study showed patients with hidradenitis suppurativa experienced significant delays in receiving a diagnosis, and these delays were associated with more severe disease burden.
Back to Top